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The endogenous ligand of guanylyl cyclase C, guany-
lin, is produced as the 94-amino-acid prohormone
proguanylin, with the hormone guanylin located at the
COOH terminus of the prohormone. The solution struc-
ture of proguanylin adopts a new protein fold and con-
sists of a three-helix bundle, a small three-stranded
-sheet of two NH2-terminal strands and one COOH-
terminal strand, and an unstructured linker region. The
sequence corresponding to guanylin is fixed in its bio-
active topology and is involved in interactions with the
NH2-terminal -hairpin: the hormone region (residues
80–94) partly wraps around the first 4 NH2-terminal res-
idues that thereby shield parts of the hormone surface.
These interactions provide an explanation for the neg-
ligible bioactivity of the prohormone as well as the im-
portant role of the NH2-terminal residues in the disul-
fide-coupled folding of proguanylin. Since the ligand
binding region of guanylyl cyclase C is predicted to be
located around an exposed -strand, the intramolecular
interactions observed between guanylin and its prose-
quence may be comparable with the guanylin/receptor
interaction.
Activation of intestinal guanylyl cyclase C (GC-C)1 results in
an increased level of intracellular cGMP. Subsequent activa-
tion of the cystic fibrosis transmembrane conductance regula-
tor leads to increased secretion of fluid and electrolytes into the
intestinal lumen. The first identified intestinal peptide hor-
mone regulating GC-C activity and thus electrolyte and fluid
secretion in the intestine is termed guanylin (1, 2).
In circulation, unlike other regulatory peptides, guanylin
predominantly occurs as the corresponding 94-amino-acid pro-
hormone, with the hormone located at its very COOH terminus
(3). Human proguanylin exhibits only negligible GC-C-activat-
ing potency (4), and the in vivo active hormone is thought to be
the 15-residue fragment proguanylin (residues 80–94) as orig-
inally isolated. This fragment would be released from the pro-
hormone by cleavage of the Asp-79–Pro-80 bond (4). This cleav-
age, however, also occurs under conditions applied during the
original isolation procedure (1, 4), and it is thus still unclear
whether Asp-79–Pro-80 is the relevant in vivo processing site.
For its biological activity, i.e. GC-C binding and activation, the
hormone requires its two disulfide bonds to be connected in a
1–3/2–4 pattern (5). This unique cysteine connectivity, how-
ever, allows formation of two interconvertable topological ste-
reoisomers (6), with only one of them (A-form) showing biolog-
ical activity (7). It has been shown that the prohormone
sequence is essential for the disulfide-coupled folding of the
hormone (4) since oxidative folding of reduced fragment
proguanylin (residues 80–94) almost completely results in the
formation of two inactive disulfide isomers. This crucial role of
the hormone prosequence for proper folding was also demon-
strated for the closely related uroguanylin prohormone (8, 9).
Unfortunately, only little structural information on prohor-
mones in general is available, and apart from different mini-
proinsulin mutants, no three-dimensional structure of any pro-
hormone has been deposited in the Protein Data Bank (PDB)
yet. Thus, the crucial questions are still open: What is the
overall topology of the prohormone? Does the hormone part of
proguanylin (residues 80–94) show structural features compa-
rable with those of the active hormone, i.e. is its topological
isomerism already present in proguanylin? How can the negli-
gible GC-C-activating potency of the prohormone be explained?
Why are the NH2-terminal residues important for disulfide-
coupled folding? Also, is the proposed processing site to release
the hormone exposed to allow attack of a putative proteinase?
In this study, we report the solution structure of progua-
nylin. In addition, by comparison of the intramolecular inter-
actions found within the proguanylin structure with the pro-
posed ligand binding region of the extracellular domain of the
guanylin receptor GC-C, we suggest a mechanism of the gua-
nylin/GC-C interaction.
EXPERIMENTAL PROCEDURES
Sample Preparation—Recombinant proguanylin was expressed as
thioredoxin fusion protein in Escherichia coli AD494 (DE3) (Novagen,
Madison, WI) and purified as described (10). For uniform (95%) 15N
and 13C/15N labeling, recombinant proguanylin was isolated and puri-
fied from E. coli cultures grown in M9 minimal medium enriched with
15NH4Cl or
15NH4Cl/
13C-glucose using the same purification protocol.
As the expression strain lacks the capability to synthesize leucine,
15N-labeled leucine was added to the medium according to the manu-
facturer’s instructions (Novagen). For NMR sample preparation, freeze-
dried protein was dissolved to final concentrations of 0.8–1.1 mM in 50
mM potassium phosphate buffer containing 10% D2O (v/v), pH 6.0, or
phosphate-buffered D2O (99.994%), pH 6.0.
NMR Spectroscopy—All NMR experiments were performed at either
293 or 298 K on Bruker Avance400 or DRX600 NMR spectrometers
(Bruker, Karlsrue, Germany) equipped with inverse 1H/13C/15N(/31P)
triple or quadruple resonance probes with pulsed-field gradient capa-
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bilities except for the 13C-NOESY-HSQC, which was recorded on a
Bruker Avance800 NMR spectrometer (Bruker, Zu¨rich, Switzerland)
equipped with an inverse 1H/13C/15N triple resonance cryoprobe with
pulsed-field gradient capabilities. In addition to the homonuclear 1H
two-dimensional COSY, TOCSY, and NOESY spectra of 2.4 mM natural
proguanylin in 0.5 ml of H2O/D2O (9:1, v/v, pH 4.0) or D2O recorded
previously (4), another two-dimensional NOESY spectrum (150-ms
mixing time) of natural proguanylin was recorded at 293 K in 0.5 ml of
50 mM potassium phosphate (containing 10% D2O, v/v, pH 6.0), the
buffer conditions that were also used for the following heteronuclear
two-dimensional and three-dimensional NMR experiments performed
on samples of uniformly 15N- or 13C/15N-labeled recombinant progua-
nylin: 15N-HSQC (11), HNHA (12, 13), 15N-TOCSY-HSQC (14) with
DIPSI-2rc (15) (80-ms mixing time), 13C-constant time HSQC (CHSQ)
(16), HNCO and HNCA (17, 18), HNCACB (19), CBCA(CO)NH (20),
HBHA(CBCACO)NH (21), and H(CCO)NH and C(CO)NH (22) with
DIPSI-2 (23) (16-ms mixing time) for the backbone and aliphatic side
chain resonance assignment, as well as 15N-NOESY-HSQC (24)
(120-ms mixing time), 13C-NOESY-HSQC (25) (150-ms mixing time),
and three-dimensional 15N-HMQC-NOESY-HSQC (26, 27) (150-ms
mixing time). Side chain 1H resonance assignments of the 8 leucine
residues were obtained exclusively from the 15N-edited spectra; a 13C/
15N F2-filtered two-dimensional NOESY spectrum (28) (150-ms mixing
time) provided additional NOESY data for these residues. Slowly ex-
changing amide protons were identified from a series of 15N-HSQC
spectra every 30 min after dissolving freeze-dried uniformly 15N-labeled
proguanylin in D2O. Amide protons still detectable after 150 min were
assumed to be involved in hydrogen bonding. DNH residual dipolar
couplings were obtained from the observed doublet splitting of uni-
formly 15N-labeled proguanylin weakly aligned by addition of 21 mg/ml
Pf1 filamentous phages (29) in in-phase/antiphase spectra (30) by sub-
tracting the 1JNH scalar coupling contribution as observed in reference
spectra of the unaligned sample. {1H}15N NOE values were measured
using the pulse sequence of Dayie and Wagner (31) with a relaxation
delay of 6 s; the evolution time increments in the indirect dimension of
the spectra with and without proton saturation by applying a train of
120° high power pulses for the final 3 s of the relaxation delay were
recorded alternately in a single combined experiment. Both DNH resid-
ual dipolar couplings and {1H}15N NOE values were averaged over two
independent data sets. The H2O resonance was suppressed with exci-
tation sculpting (32), a binomial 3-9-19 WATERGATE sequence (33)
with water flip-back (34), and gradient coherence selection (35) in
the homonuclear 1H experiments, the amide-detected experiments
except for the 15N-TOCSY-HSQC, and the remaining experiments,
respectively.
Quadrature detection in the indirectly detected dimensions was ob-
tained by the States-TPPI method (36, 37) or by the echo-antiecho
method (38) if coherence selection with gradients was employed (35, 39).
Carbon pulses were typically applied as band-selective rectangular,
BURP (40), or Gaussian cascade (41) pulses for discriminating aliphatic
and carbonyl resonances (42). WALTZ-16 (43), GARP (44), and MLEV-4
expanded off-resonant Gaussian pulse cascades (45) were employed for
broadband 1H, broadband 13C or 15N, and band-selective 13C hetero-
nuclear decoupling, respectively. Multidimensional NMR data were
extrapolated to up to twice the acquisition time by linear prediction in
one of the 13C or 15N indirect dimensions, apodized by multiplication
with squared sine bells shifted by 60–90°, and extended to at least twice
the length by zero-filling in all dimensions prior to Fourier transforma-
tion. The baseline in the direct dimension was corrected using a model-
free algorithm (46). The NMR data were processed using in-house
written software (47) and analyzed with the program packages NMR-
View (48) and NDEE (SpinUp Inc., Dortmund, Germany). 1H chemical
shifts were referenced with respect to external 2,2-dimethyl-2-silapen-
tane-5-sulfonic acid in D2O, and
13C and 15N chemical shifts were
referenced indirectly (49).
Structure Calculation—Distance restraints for structure calculation
were taken from the 15N-NOESY-HSQC spectrum for NOEs involving
amide protons and from the 13C-NOESY-HSQC spectrum and homo-
nuclear NOESY spectra for NOEs between aliphatic and aromatic
protons. 3J(HN,H) coupling constants were calculated from cross-peak
to diagonal peak intensity ratios in the HNHA spectrum and corrected
by a factor of 1.05 to account for the different relaxation rates of the
in-phase and the antiphase component (12), as well as from line-shape
analysis of the antiphase cross-signal splitting in a high digital resolu-
tion double quantum filtered (DQF)-COSY spectrum using a Lorentzian
function for peak fitting.
The non-trivial unambiguous NOESY cross-peaks used for structure
calculation were classified manually according to the relative intensi-
ties and converted into upper distance constraints: strong, 2.7 Å; me-
dium, 3.5 Å; and weak, 5.0 Å. 3J(HN,H) coupling constants were con-
verted into -angles according to the Karplus equation as described
(50). All 11 proline residues were considered to have trans conformation
as evidenced by characteristic C and C chemical shifts (51), unam-
biguous H(i) Pro-H(i1) NOE signals in the 13C-NOESY-HSQC, and
two-dimensional NOESY spectra and the fact that H(i) Pro-H(i1)
and HN(i) Pro-H(i1) connectivities were absent (52). Disulfide bonds
were taken into account by one NOE distance restraint dSS  2.02 
0.10 Å) for each disulfide bond. Hydrogen bonds were selected as de-
scribed (50, 53) and introduced into the calculation by two distance
restraints each (54).
Structures were calculated with X-PLOR 3.851 (50, 55) using a
three-stage simulated annealing protocol (56) with floating assignment
of prochiral groups (57). To improve the stereochemical quality of the
structures, a modified conformational data base potential for backbone
and side chain dihedral angles was used (58, 59). The simulated an-
nealing was followed by 1200 steps of energy minimization, with the
final 1000 steps without conformational data base potential.
Ambiguities in the NOE cross-peak assignments were solved in an
iterative approach using several rounds of structure calculations with
subsequent distance analysis. Dihedral angle and hydrogen bond con-
straints were introduced in later rounds of the structure calculation. Of
the 120 structures resulting from the final round of structure calcula-
tion, the 40 structures with the lowest overall energies and experimen-
tal restraint violations were selected for refinement using additional
restraints from residual dipolar couplings: a previously described grid
search procedure (53) was applied to obtain the axial component and
rhombicity of the alignment tensor using the tensor components of the
structures calculated without residual dipolar couplings as starting
values. The selected structures were refined using the value of the
alignment tensor with the best agreement between measured and cal-
culated residual dipolar couplings. Refinement comprised simulated
annealing with a harmonic X-PLOR potential energy term for the
dipolar couplings included in the target function of the simulated an-
nealing protocol during the cooling stages. The force constant of the
alignment tensor was increased gradually from 0.01 to 1.0 kcal mol1
Hz2. After refinement, the 30 structures with the lowest overall ener-
gies and restraint violations were used for further characterization. The
geometry of the structures as well as elements of secondary structure
were analyzed using PROCHECK (60) and MOLMOL (61). MOLMOL
(61) was used for visualization of the structure data.
Data Bank Accession Numbers—The coordinates and NMR re-
straints have been deposited in the Protein Data Bank (PDB accession
number: 1o8r), and chemical shift values and coupling constants have
been deposited in the BioMagResBank (accession number: 5603).
RESULTS
Structure Determination—Based on an almost complete se-
quence-specific assignment of the backbone (Fig. 1) as well as
the side chain resonances of recombinant proguanylin (only the
spin system of Leu-47 could not be assigned due to severe
spectral overlap), a total of 700 experimental restraints were
derived from the NMR spectra. All distance restraints are
intramolecular, as natural (i.e. proguanylin isolated from hu-
man blood ultrafiltrate) as well as recombinant proguanylin
are monomeric in solution at concentrations used for the NMR
experiments (10).
The experimental restraints consist of 591 distance con-
straints that were derived from the NOE data in an iterative
manner, 30 dihedral angle constraints, 24 hydrogen bonds, and
55 residual dipolar couplings (Table I). 457 NOEs detected in
the 15N-NOESY-HSQC could be used as distance restraints,
and 65 distance restraints could be obtained from the 13C-
NOESY-HSQC spectrum. Additional experimental restraints
were derived from the two-dimensional NOESY and COSY
spectra of natural proguanylin, providing 69 non-redundant
NOEs and 11 3J(HN,H) coupling constants. These restraints
were particularly valuable, as they mainly involved long range
interactions between aromatic and/or aliphatic side chains that
form a hydrophobic core. From the family of 120 structures of
the final round of calculations, the 40 structures with the
lowest overall energies were chosen for refinement using 55
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additional restraints from residual dipolar couplings. Inclusion
of these additional restraints increased the precision of the 30
lowest energy structures: the r.m.s.d. of the backbone heavy
atoms of elements with regular secondary structure decreased
from 0.43 to 0.40 Å. The r.m.s.d. between the average struc-
tures of both calculations is 0.59 Å, showing that the orienta-
tion of the N-H vectors agree with the overall backbone topol-
ogy derived from conventional NMR data. From the 40
structures used for refinement, the 30 lowest energy structures
were chosen to represent the solution conformation of progua-
nylin (Fig. 2). These structures show only small deviations in
overall energies and r.m.s.d. values from ideal geometry (Table
I). This is also confirmed by the PROCHECK analysis (60),
showing favorable backbone conformations for almost all resi-
dues of the 30 structures with 80.5% of the non-glycine and
non-proline residues in the most favored regions and 18.5% in
additional allowed regions of the Ramachandran plot. The
structures show no distance violations greater than 0.13 Å and
no dihedral angle restraint violations greater than 5°.
The best fit backbone superposition of the 30 lowest overall
energy structures of proguanylin (Fig. 2) shows a globularly
folded protein with well defined elements of regular secondary
structure. The r.m.s.d. of the converging structures is 1.27 Å for
the backbone heavy atoms and 1.89 Å for all heavy atoms.
Omission of the unstructured central linker sequence (residues
22–45) results in lower r.m.s.d. values of 0.69 and 1.14 Å, and
elements of regular secondary structure show r.m.s.d. values of
0.40 and 0.90 Å, respectively (Table I).
Description of the Proguanylin Structure—The solution
structure of proguanylin consists of a three-helix bundle and a
small triple-stranded antiparallel -sheet of two strands at the
NH2 terminus (Thr-2 to Gln-4, Ser-9 to Phe-10) and one strand
at the very COOH terminus (Cys-91 to Thr-92; Figs. 2 and 5A).
FIG. 1. 15N HSQC spectrum of 15N-labeled proguanylin. The
almost complete resonance assignment is indicated. Peaks correspond-
ing to side chains of the same Asn or Gln residue are connected by
horizontal lines. Aliased peaks are colored gray. The spectrum was
recorded at 293 K and 600 MHz (1.1 mM protein in 50 mM potassium
phosphate/10% D2O, pH 6.0).
TABLE I
Summary of structure calculation
Except for the experimental restraints all values are average values
over the 30 final structures in the form average value ( standard
deviation).
Experimental restraints for final structure calculation
Interresidual NOEs 547
Sequential (i  j  1) 257
Medium range (i  j  5) 154
Long range (i  j  5) 136
Intraresidual NOEs 44
Dihedral angle restraints
From 3J(H,NH) 30
Hydrogen bonds 24
Restraints from dipolar couplings 55
Molecular dynamics statistics
Average energy (kcal/mol)
Etot 183.69 ( 5.98)
Ebond 5.32 ( 0.23)
Eangles 141.46 ( 2.22)
Eimproper 14.05 ( 0.56)
Erepel 12.49 ( 2.67)
ENOE 4.39 ( 1.19)
Ecdih 0.14 ( 0.097)
Edipo 5.84 ( 1.31)
r.m.s.d. from ideal distances (Å)
NOE 0.012 ( 0.0015)
Bonds 0.0048 ( 0.00039)
r.m.s.d. from ideal angles (deg)
Bond angles 1.20 ( 0.22)
Improper angles 0.45 ( 0.0057)
r.m.s.d. from dipolar couplings (Hz)
H-N couplings 0.65 ( 0.31)
Atomic r.m.s.d. differences from the average structure
Backbone Heavy atoms
Å Å
Overalla 1.27 1.89
Residues 1–21, 46–94 0.69 1.14
Regular secondary structureb 0.40 0.90
SARDC vs. SAnoRDC
c 0.59 0.68
a Calculated for the final set of 30 structures (residues 1–94).
b Calculated for the final set of 30 structures (residues 2–4, 9–10,
12–17, 54–62, 66–78, 91–92).
c SARDC, average structure of the final 30 structures calculated with
dipolar couplings; SAnoRDC, average structure of 30 structures calcu-
lated without dipolar couplings (calculated for residues 1–21, 46–94).
RDC, residual dipolar couplings.
FIG. 2. Stereoview of the best-fit backbone superposition of
the 30 final proguanylin structures. Helices (red), -sheet structure
(green), and regions with low {1H}15N heteronuclear NOE values (gray)
are indicated. Side chains forming the hydrophobic core (yellow) are
labeled by residue number (Phe-10, Val-15, Leu-18, Phe-53, Leu-57,
Leu-60, Leu-73). The fit is performed for the C atoms of the regular
secondary structure (residues 2–4, 9–10, 12–17, 54–62, 66–78, 91–92)
(figure generated with MOLMOL (61)).
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The relative orientation of these structural elements is fixed by
a hydrophobic core (Phe-10, Val-15, Leu-18, Phe-53, Leu-57,
Leu-60, and Leu-73) whose rigidity is reflected by a high num-
ber of long range NOEs (Figs. 2 and 3B). Three regular -hel-
ices (Leu-12 to Lys-17, Leu-57 to Lys-62, Ala-66 to Glu-78) are
evidenced by several N(i, i4) NOEs with helix 2 preceded by
a short 310-helix turn from Pro-54 to Glu-56.
The linker region (Gln-22 to Pro-45) connecting the first two
helices is less well defined (Fig. 2), as evidenced by high local
r.m.s.d. values (Fig. 3A), a relatively low number of detectable
NOEs (Fig. 3B), and a rapid solvent exchange of the amide
protons. The values of the {1H}15N heteronuclear NOEs for the
amide protons of Gln-22 to Val-44 are all smaller than 0.6 with
the lowest value of 0.08 for Ile-38, clearly indicating a signifi-
cantly increased inherent flexibility of the N-H vectors on a
pico- to nanosecond time scale (Fig. 3C) (62).
DISCUSSION
The roles of the prosequences for the disulfide-coupled fold-
ing and biological activity of the related peptide hormones
guanylin and uroguanylin have been investigated previously
(4, 8, 9), but the oligomerization state of both prohormones was
unclear. In a recent study, we showed by analytical ultracen-
trifugation that proguanylin is monomeric in solution up to the
millimolar range (10), the concentration used for the NMR
experiments. This result evidenced that all distance restraints
that were derived from the NMR data are intramolecular.
Additionally, we could show that natural and recombinant
proguanylin that were both used for structure determination
feature identical biophysical and biochemical properties, al-
though recombinant proguanylin possesses an additional Gly
and Pro residue at its NH2 terminus (10).
Relevance of the NH2-terminal Residues in the Disulfide-
coupled Folding of Proguanylin—A major function of the gua-
nylin prosequence is the disulfide-coupled folding of this pep-
tide hormone (4). In vitro folding experiments with proguanylin
lacking the first 31 amino acids almost exclusively resulted in
products with non-native disulfide connectivities (4). A similar
observation was made for the related uroguanylin precursor
protein, where correct oxidative folding is prevented on trun-
cation of the first 6 residues in vitro and in vivo (9). Residues
Thr-2 to Gln-4 form the central strand of the triple-stranded
-sheet connecting the termini (Figs. 2, 5A, and 6), and trun-
cation of the first 6 residues corresponds to deletion of the first
-strand, leading to loss of the interaction between the termini.
These tertiary contacts have been shown to be sufficient for the
proper conformation of the hormone part (see below), which is
likely to be a requisite for generation of the correct disulfide
connectivities.
In Its Precursor Protein, Guanylin Adopts the A-form Topol-
ogy—The originally isolated hormone guanylin is a 15-amino-
acid peptide corresponding to proguanylin (residues 80–94). It
possesses two disulfide bonds in a 1–3/2–4 connectivity that
are essential for its bioactivity (1, 5). Although this disulfide
pattern is unique, guanylin is able to form two interconverting
topological stereoisomers (6), with only one of them, the A-
form, showing significant biological effects (7).
The two isomers are defined by the relative orientation of the
loop between the central cystein residues (corresponding resi-
dues of the prohormone: Cys-86 and Cys-91) toward the plane
formed by the disulfide bonds (6). Both isomers can be distin-
guished by their distinct sets of spin systems (6, 7). For resi-
dues 80–94 of proguanylin, only one set of spin systems could
be identified in the NMR spectra with chemical shifts similar to
those observed for the A-isomer (Fig. 4): for residues exhibiting
the most pronounced differences between the H secondary
chemical shifts of guanylin isomers A and B, the corresponding
residues of proguanylin are more similar to the A-isomer. The
same applies for the amide proton shifts (data not shown).
Noticeable chemical shift differences between both guanylin
isomers and proguanylin residues 82–84 (upfield shift) and
91–93 (downfield shift) are due to secondary structural ele-
FIG. 3. Atomic r.m.s.d. from the average structure (A), distri-
bution of NOEs (B), and {1H}15N NOE values (C). The r.m.s.d.
values for the backbone and all heavy atoms are displayed as filled and
open circles, respectively. The average structure of proguanylin was
calculated for elements of regular secondary structure (residues 2–4,
9–10, 12–17, 54–62, 66–78, 91–92). Intraresidual (black), sequential
(medium gray), medium range (dark gray), and long range (light gray)
NOEs are displayed as vertical stacked bars. {1H}15N NOE values at 600
MHz are displayed as vertical bars with error bars on top.
FIG. 4. H secondary chemical shifts of proguanylin residues
82–94 and the guanylin A- and B-isomers. The H secondary chem-
ical shifts were calculated using the random coil values given by
Wishart et al. (73). Chemical shifts of the guanylin A-form (PDB acces-
sion number 1gna) and B-form (PDB accession number 1gnb) are taken
from Skelton et al. (6).
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ments, i.e. a helical turn (residues 81–84) and the COOH-
terminal -strand (residues 91–92) (Figs. 4 and 5).
Since the NMR spectra show several additional peaks of
weaker intensity (Fig. 1), these resonances were examined
according to a second hormone topology. However, these addi-
tional resonances are due to cis-trans isomerization of the 6
proline residues present in the unstructured linker region and
to small conformational differences in disulfide bond geometry.
Therefore, it is evident that the topological isomerism found for
the mature peptide is not present in the precursor protein. In
the experimentally determined proguanylin structure, the ori-
entation of the residues corresponding to the central loop re-
gion (Ala-87 to Ala-90) is similar to that found for the A-isomer
of guanylin (Fig. 5, B and C): the r.m.s.d. value between the
backbone heavy atoms of proguanylin residues 82–94 (Fig. 5B)
and the guanylin A-form (Fig. 5C; PDB accession number 1gna)
is 1.62 Å, whereas the r.m.s.d. value for the guanylin B-form
(PDB accession number 1gnb) is 5.09 Å.
The A-isomer topology is stabilized in a way that the hor-
mone region of proguanylin partly wraps around the NH2-
terminal -strand, with residues Val-1 and Val-3 positioned
below the plane formed by the disulfide bonds (Cys-83–Cys-91/
Cys-86–Cys-94) (Fig. 6). As a result, in addition to the -sheet
typical backbone/backbone interactions between the hormone
part (residues 80–94) and the NH2 terminus, further backbone/
backbone, backbone/side chain, and side chain/side chain inter-
actions are present (Fig. 6), as verified by several NOE connec-
tivities, mainly involving residues Val-1 to Gln-4, Cys-86, and
Ala-90 to Cys-94. Assuming a hypothetical B-form topology,
similar interactions between the hormone part and the prose-
quence would be sterically unfavored. Thus, the interactions
between the termini together with structural features of the
prosequence seem to be a commensurate condition for the sta-
bilization of the A-form topology within proguanylin (Fig. 6).
Possible Causes for the Missing Bioactivity of Proguanylin—
Although proguanylin residues 80–94 exhibit the bioactive A-
isomer topology, the prohormone is almost inactive with re-
spect to GC-C activation (4) due to a significantly decreased
receptor binding affinity (63). In contrast, the 32-amino-acid
fragment proguanylin (residues 62–94) is able to bind to GC-C
with an affinity similar to the biologically active proguanylin
(residues 73–94) (63, 64) but is inactive in a T84/cGMP assay
(4). As outlined above, the first NH2-terminal residues of
proguanylin including the first -strand shield part of the
hormone surface (Fig. 6), which is therefore not accessible for
contacts to GC-C, explaining the significantly decreased recep-
tor binding affinity. This intramolecular interaction is not pos-
sible in the NH2-terminally truncated fragment proguanylin
(residues 62–94), which is therefore able to bind to GC-C. Thus,
its missing activating potency might be due to sterical proper-
ties of the ligand/receptor interaction: for the natriuretic pep-
tide clearance receptor (CNPR) with a ligand binding domain
homologous to GC-C, the ligand binds to a cleft formed by the
two monomer halves of the dimeric receptor (65). Assuming a
similar situation for GC-C, which is, like CNPR, an oligomer
prior to ligand binding, the conformational changes necessary
for receptor activation might be influenced by the size of the
ligand. Further proof of this hypothesis, however, requires
structure determination of the guanylin/GC-C complex.
Interaction of Guanylin with Its Receptor GC-C—The extra-
cellular ligand binding domain of GC-C (GC-CECD) is proposed
to adopt a periplasmic binding protein (PBP) type I-like fold
(66) and is predicted (67) to be structurally similar to the
dimerized ligand binding domains of the natriuretic peptide
clearance receptor (CNPR; PDB accession number 1jdp) and
the guanylyl cyclase-coupled atrial natriuretic peptide receptor
(PDB accession number 1dp4). Mapping of the known biochem-
ical data (68–70) on a structural model of GC-C, which is based
on these two receptor structures (data not shown), restricts the
ligand binding region to a sequence around an exposed and
accessible -strand. Since in its prohormone form guanylin
FIG. 5. Schematic representation of the proguanylin struc-
ture. A, schematic drawing of a representative structure of proguanylin
indicating elements of regular secondary structure (for elements of
regular secondary structure, the same color code is used as in Fig. 2).
Disulfide bonds between residues 48–61, 83–91, and 86–94 are dis-
played in yellow. B, A-isomer topology of the hormone region of progua-
nylin (residues 80–94). As compared with the view in A, the molecule is
rotated by 90° around a vertical axis and zoomed. C, guanylin A-isomer
(6) (PDB accession number 1gna) (figure generated with MOLMOL
(61)).
FIG. 6. Interaction of the proguanylin hormone region with
the NH2 terminus. In A, a representative structure of proguanylin is
shown. Compared with the view in Fig. 5A, the molecule is rotated by
45° around a vertical axis. B, top view. Helices and the NH2-terminal
-sheet are colored red and green, respectively. Residues Val-1 to Gln-4
are displayed as space-filled atoms, and residues 80–94 are shown in
stick representation (blue; space fill is indicated) (figure generated with
RasMol (74)).
FIG. 7. Sequence alignment (75) of proguanylin and
prouroguanylin. Identical residues are displayed in red, conserved
and semiconserved substitutions are colored green and blue, respec-
tively. The experimentally determined (A) and predicted (76) (B) sec-
ondary structures are indicated.
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binds to the NH2-terminal residues and forms an intramolec-
ular triple-stranded -sheet (Figs. 5 and 6), it is likely that the
same kind of interaction is present in the binding of guanylin to
its receptor.
Analysis of Possible Proteinase Cleavage Sites—The native
processing site to release the bioactive hormone from its
prosequence could not be identified so far as the originally
isolated and bioactive 15-residue guanylin can be released
from the prohormone by acidic cleavage of an Asp-Pro bond
(4), a process that also occurs under conditions applied dur-
ing the original isolation procedure (1, 4). In the proguanylin
structure, this Asp-79–Pro-80 bond is located in the exposed
linker region between helix 3 and residues 80–94 (Fig. 5),
allowing attack of a potential proteinase without unfolding of
the protein. However, no such proteinase has been identified
yet. Processing of proguanylin by trypsin digestion results,
among others, in the COOH-terminal fragment proguanylin
(residues 73–94), which possesses the same biological activity
as proguanylin (residues 80 –94) (64). The corresponding
cleavage site is located at the outside of helix 3 and partly
solvent-accessible. This may well mean that Arg-72–Leu-73
is the relevant in vivo processing site.
Proguanylin Adopts a New Protein Fold—Only few structural
studies on prohormones are published, and of these, only the
three-dimensional structures of mini-proinsulin mutants (PDB
accession numbers: 1efe, 1sjt, 1sju) have been deposited in the
PDB. Analyzing the sequence of proguanylin with 3D-PSSM (67),
a program that is able to recognize remote protein sequence
homologues as well as structural relationships, no structural
homologue with a significant score was found. A DALI protein
structure comparison search (71) with the experimentally deter-
mined structure of proguanylin came up without a result,
strongly supporting the suggestion that proguanylin adopts a
new protein fold.
The Related Prouroguanylin Likely Adopts a Fold Similar to
Proguanylin—For the related peptide hormones guanylin and
uroguanylin, a similar equilibrium between two topological
stereoisomers (A- and B-form) can be observed (6, 72), and both
peptides adopt similar three-dimensional structures (guanylin,
PDB accession numbers: 1gna, 1gnb; uroguanylin, PDB acces-
sion numbers: 1uya, 1uyb). Furthermore, an essential contri-
bution of the prosequences of both hormones to the in vitro
disulfide-coupled folding was demonstrated (4, 8, 9). Addition-
ally, digestion of prouroguanylin with endoproteinase Arg-C
and subsequent high performance liquid chromatography anal-
ysis showed that the uroguanylin A-form was released exclu-
sively (8). This is similar to the hormone topology observed in
the proguanylin structure (Fig. 5B). Alignment of the two pro-
tein sequences reveals a sequence identity of 35% (Fig. 7). The
main difference is a deletion of 7 amino acid residues in the
central sequence stretch, located in the flexible linker region of
the proguanylin structure. Furthermore, the predicted second-
ary structure of prouroguanylin closely resembles the experi-
mentally determined one of proguanylin (Fig. 7). Taking all
these findings together, proguanylin is a suitable template for
homology modeling of prouroguanylin, resulting in similar
three-dimensional structures for both proteins (model not
shown).
We conclude that the two reported functions of the guanylin
prosequence, i.e. inactivation of the hormone region and disul-
fide-coupled folding, are mediated by interactions between NH2
and COOH terminus: the interstrand contacts of the small
triple stranded -sheet effectively shield the hormone region
and are a commensurate condition for an A-form like hormone
topology and also for disulfide-coupled folding. Additional rea-
sons for the missing bioactivity of proguanylin and the frag-
ment proguanylin (residues 63–94), like sterical properties,
however, cannot totally be excluded.
REFERENCES
1. Currie, M. G., Fok, K. F., Kato, J., Moore, R. J., Hamra, F. K., Duffin, K. L., and
Smith, C. E. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 947–951
2. Forte, L. R. (1999) Regul. Pept. 81, 25–39
3. Kuhn, M., Raida, M., Adermann, K., Schulz-Knappe, P., Gerzer, R., Heim,
J. M., and Forssmann, W. G. (1993) FEBS Lett. 318, 205–209
4. Schulz, A., Marx, U. C., Hidaka, Y., Shimonishi, Y., Ro¨sch, P., Forssmann,
W. G., and Adermann, K. (1999) Protein Sci. 8, 1850–1859
5. Klodt, J., Kuhn, M., Marx, U. C., Martin, S., Rosch, P., Forssmann, W. G., and
Adermann, K. (1997) J. Pept. Res. 50, 222–230
6. Skelton, N. J., Garcia, K. C., Goeddel, D. V., Quan, C., and Burnier, J. P. (1994)
Biochemistry 33, 13581–13592
7. Schulz, A., Escher, S., Marx, U. C., Meyer, M., Ro¨sch, P., Forssmann, W. G.,
and Adermann, K. (1998) J. Pept. Res. 52, 518–525
8. Hidaka, Y., Ohno, M., Hemmasi, B., Hill, O., Forssmann, W. G., and Shimon-
ishi, Y. (1998) Biochemistry 37, 8498–8507
9. Hidaka, Y., Shimono, C., Ohno, M., Okumura, N., Adermann, K., Forssmann,
W. G., and Shimonishi, Y. (2000) J. Biol. Chem. 275, 25155–25162
10. Lauber, T., Nourse, A., Schulz, A., and Marx, U. C. (2002) Biochemistry 41,
14602–14612
11. Mori, S., Abeygunawardana, C., Johnson, M. O., and Vanzijl, P. C. M. (1995)
J. Magn. Reson. Series B 108, 94–98
12. Vuister, G. W., and Bax, A. (1993) J. Am. Chem. Soc. 115, 7772–7777
13. Zhang, W., Smithgall, T., and Gmeiner, W. H. (1997) J. Biomol. NMR 10,
263–272
14. Zhang, O., Kay, L. E., Olivier, J. P., and Forman-Kay, J. D. (1990) J. Biomol.
NMR 4, 845–858
15. Cavanagh, J., and Rance, M. (1992) J. Magn. Reson. 96, 670–678
16. Vuister, G. W., and Bax, A. (1992) J. Magn. Reson. 98, 428–435
17. Ikura, M., Kay, L. E., and Bax, A. (1990) Biochemistry 29, 4659–4667
18. Grzesiek, S., and Bax, A. (1992) J. Magn. Reson. 96, 432–440
19. Wittekind, M., and Mueller, L. (1993) J. Magn. Reson., Series B 101, 201–205
20. Grzesiek, S., and Bax, A. (1992) J. Am. Chem. Soc. 114, 6291–6293
21. Grzesiek, S., and Bax, A. (1993) J. Biomol. NMR 3, 185–204
22. Grzesiek, S., Anglister, J., and Bax, A. (1993) J. Magn. Reson., Series B 101,
114–119
23. Shaka, A. J., Lee, C. J., and Pines, A. (1988) J. Magn. Reson. 77, 274–293
24. Talluri, S., and Wagner, G. (1996) J. Magn. Reson., Series B 112, 200–205
25. Ikura, M., Kay, L. E., Tschudin, R., and Bax, A. (1990) J. Magn. Reson. 86,
204–209
26. Frenkiel, T., Bauer, C., Carr, M. D., Birdsall, B., and Feeney, J. (1990) J.
Magn. Reson. 90, 420–425
27. Ikura, M., Bax, A., Clore, G. M., and Gronenborn, A. M. (1990) J. Am. Chem.
Soc. 112, 9020–9022
28. Zwahlen, C., Legault, P., Vincent, S. J. F., Greenblatt, J., Konrat, R., and Kay,
L. E. (1997) J. Am. Chem. Soc. 119, 6711–6721
29. Hansen, M. R., Mueller, L., and Pardi, A. (1998) Nat. Struct. Biol. 5,
1065–1074
30. Ottiger, M., Delaglio, F., and Bax, A. (1998) J. Magn. Reson. 131, 373–378
31. Dayie, K. T., and Wagner, G. (1994) J. Magn. Reson., Series A 111, 121–126
32. Hwang, T. L., and Shaka, A. J. (1995) J. Magn. Reson., Series A 112, 275–279
33. Sklenar, V., Piotto, M., Leppik, R., and Saudek, V. (1993) J. Magn. Reson.,
Series A 102, 241–245
34. Grzesiek, S., and Bax, A. (1993) J. Am. Chem. Soc. 115, 12593–12594
35. Schleucher, J., Schwendinger, M. G., Sattler, M., Schmidt, P., Schedletzky, O.,
Glaser, S. J., Sørensen, O. W., and Griesinger, C. (1994) J. Biomol. NMR 4,
301–306
36. States, D. J., Haberkorn, R. A., and Ruben, D. J. (1982) J. Magn. Reson. 48,
286–292
37. Marion, D., Ikura, M., Tschudin, R., and Bax, A. (1989) J. Magn. Reson. 85,
393–399
38. Kay, L. E., Keifer, P., and Saarinen, T. (1992) J. Am. Chem. Soc. 114,
10663–10665
39. Sattler, M., Schwendinger, M. G., Schleucher, J., and Griesinger, C. (1995)
J. Biomol. NMR 5, 11–22
40. Geen, H., and Freeman, R. (1991) J. Magn. Reson. 93, 93–141
41. Emsley, L., and Bodenhausen, G. (1990) Chem. Phys. Lett. 165, 469–476
42. Sattler, M., Schleucher, J., and Griesinger, C. (1999) Prog. NMR Spectrosc. 34,
93–158
43. Shaka, A. J., Keeler, J., Frenkiel, T., and Freeman, R. (1983) J. Magn. Reson.
52, 335–338
44. Shaka, A., Barker, P. B., and Freeman, R. (1985) J. Magn. Reson. 64, 547–552
45. Eggenberger, U., Schmidt, P., Sattler, M., Glaser, S. J., and Griesinger, C.
(1992) J. Magn. Reson. 100, 604–610
46. Friedrich, M. S. (1995) J. Biomol. NMR 5, 147–153
47. Schweimer, K. (2000) Mehrdimensionale NMR Spektoskopie zur Bestimmung
der Strukturen des Birkenpollenallergens Bet v 1, des Guillardia theta
Rubredoxins und des [2Fe-2S] Ferredoxins aus Halobakterium salinarium.
Doctoral Dissertation, University of Bayreuth, Bayreuth, Germany
48. Johnson, B. A., and Blevins, R. A. (1994) J. Biomol. NMR 4, 603–614
49. Markley, J. L., Bax, A., Arata, Y., Hilbers, C. W., Kaptein, R., Sykes, B. D.,
Wright, P. E., and Wu¨thrich, K. (1998) Pure Appl. Chem. 70, 117–142
50. Neudecker, P., Schweimer, K., Nerkamp, J., Scheurer, S., Vieths, S., Sticht, H.,
and Ro¨sch, P. (2001) J. Biol. Chem. 276, 22756–22763
51. Hill, J. M., Alewood, P. F., and Craik, D. J. (1996) Biochemistry 35, 8824–8835
52. Wu¨thrich, K. (1986) NMR of Proteins and Nucleic Acids, pp. 122–125, John
Wiley & Sons, Inc., New York
53. Schweimer, K., Hoffmann, S., Bauer, F., Friedrich, U., Kardinal, C., Feller,
S. M., Biesinger, B., and Sticht, H. (2002) Biochemistry 41, 5120–5130
Solution Structure of Proguanylin 24123
 at UQ Library on September 5, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
54. Kraulis, J., Clore, G. M., Nilges, M., Jones, T. A., Pettersson, G., Knowles, J.,
and Gronenborn, A. M. (1989) Biochemistry 28, 7241–7257
55. Bru¨nger, A. T. (1993) X-PLOR, Version 3.1, a system for X-ray crystallography
and NMR, Yale University Press, New Haven, CT
56. Nilges, M. (1993) Proteins 17, 297–309
57. Folmer, R. H., Hilbers, C. W., Konings, R. N., and Nilges, M. (1997) J. Biomol.
NMR 9, 245–258
58. Kuszewski, J., and Clore, G. M. (2000) J. Magn. Reson. 146, 249–254
59. Neudecker, P., Sticht, H., and Ro¨sch, P. (2001) J. Biomol. NMR 21, 373–375
60. Laskowski, R. A., MacArthur, M. W., Moss, D. S., and Thornton, J. M. (1993)
J. Appl. Cryst 26, 283–291
61. Koradi, R., Billeter, M., and Wuthrich, K. (1996) J. Mol. Graph. 14, 29–32
62. Kay, L. E., Torchia, D. A., and Bax, A. (1989) Biochemistry 28, 8972–8979
63. Garcia, K. C., de Sauvage, F. J., Struble, M., Henzel, W., Reilly, D., and
Goeddel, D. V. (1993) J. Biol. Chem. 268, 22397–22401
64. de Sauvage, F. J., Keshav, S., Kuang, W. J., Gillett, N., Henzel, W., and
Goeddel, D. V. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 9089–9093
65. He, X., Chow, D., Martick, M. M., and Garcia, K. C. (2001) Science 293,
1657–1662
66. van den Akker, F. (2001) J. Mol. Biol. 311, 923–937
67. Kelley, L. A., MacCallum, R. M., and Sternberg, M. J. (2000) J. Mol. Biol. 299,
501–522
68. Hasegawa, M., Hidaka, Y., Matsumoto, Y., Sanni, T., and Shimonishi, Y.
(1999) J. Biol. Chem. 274, 31713–31718
69. Wada, A., Hirayama, T., Kitaura, H., Fujisawa, J., Hasegawa, M., Hidaka, Y.,
and Shimonishi, Y. (1996) Infect. Immun. 64, 5144–5150
70. Hidaka, Y., Matsumoto, Y., and Shimonishi, Y. (2002) FEBS Lett. 526, 58–62
71. Holm, L., and Sander, C. (1993) J. Mol. Biol. 233, 123–138
72. Marx, U. C., Klodt, J., Meyer, M., Gerlach, H., Ro¨sch, P., Forssmann, W. G.,
and Adermann, K. (1998) J. Pept. Res. 52, 229–240
73. Wishart, D. S., Bigam, C. G., Holm, A., Hodges, R. S., and Sykes, B. D. (1995)
J. Biomol. NMR 5, 67–81
74. Sayle, R. (1995) RasMol, V2.6, molecular visualization program, Glaxo Well-
come Research and Development, Stevevage, Hertfordshire, UK
75. Thompson, J. D., Higgins, D. G., and Gibson, T. J. (1994) Nucleic Acids Res. 22,
4673–4680
76. Jones, D. T. (1999) J. Mol. Biol. 292, 195–202
Solution Structure of Proguanylin24124
 at UQ Library on September 5, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
Thomas Lauber, Philipp Neudecker, Paul Rösch and Ute C. Marx
PROSEQUENCE
Solution Structure of Human Proguanylin: THE ROLE OF A HORMONE
doi: 10.1074/jbc.M300370200 originally published online April 21, 2003
2003, 278:24118-24124.J. Biol. Chem. 
  
 10.1074/jbc.M300370200Access the most updated version of this article at doi: 
 Alerts: 
  
 When a correction for this article is posted•  
 When this article is cited•  
 to choose from all of JBC's e-mail alertsClick here
  
 http://www.jbc.org/content/278/26/24118.full.html#ref-list-1
This article cites 65 references, 9 of which can be accessed free at
 at UQ Library on September 5, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
